TY - JOUR
T1 - Key contribution of CPEB4-mediated translational control to cancer progression
AU - Ortiz-Zapater, Elena
AU - Pineda, David
AU - Martinez-Bosch, Neus
AU - Fernandez-Miranda, Gonzalo
AU - Iglesias, Mar
AU - Alameda, Francesc
AU - Moreno, Mireia
AU - Eliscovich, Carolina
AU - Eyras, Eduardo
AU - Real, Francisco X.
AU - Mendez, Raul
AU - Navarro, Pilar
PY - 2012/1
Y1 - 2012/1
N2 - Malignant transformation, invasion and angiogenesis rely on the coordinated reprogramming of gene expression in the cells from which the tumor originated. Although deregulated gene expression has been extensively studied at genomic and epigenetic scales, the contribution of the regulation of mRNA-specific translation to this reprogramming is not well understood. Here we show that cytoplasmic polyadenylation element binding protein 4 (CPEB4), an RNA binding protein that mediates meiotic mRNA cytoplasmic polyadenylation and translation, is overexpressed in pancreatic ductal adenocarcinomas and glioblastomas, where it supports tumor growth, vascularization and invasion. We also show that, in pancreatic tumors, the pro-oncogenic functions of CPEB4 originate in the translational activation of mRNAs that are silenced in normal tissue, including the mRNA of tissue plasminogen activator, a key contributor to pancreatic ductal adenocarcinoma malignancy. Taken together, our results document a key role for post-transcriptional gene regulation in tumor development and describe a detailed mechanism for gene expression reprogramming underlying malignant tumor progression.
AB - Malignant transformation, invasion and angiogenesis rely on the coordinated reprogramming of gene expression in the cells from which the tumor originated. Although deregulated gene expression has been extensively studied at genomic and epigenetic scales, the contribution of the regulation of mRNA-specific translation to this reprogramming is not well understood. Here we show that cytoplasmic polyadenylation element binding protein 4 (CPEB4), an RNA binding protein that mediates meiotic mRNA cytoplasmic polyadenylation and translation, is overexpressed in pancreatic ductal adenocarcinomas and glioblastomas, where it supports tumor growth, vascularization and invasion. We also show that, in pancreatic tumors, the pro-oncogenic functions of CPEB4 originate in the translational activation of mRNAs that are silenced in normal tissue, including the mRNA of tissue plasminogen activator, a key contributor to pancreatic ductal adenocarcinoma malignancy. Taken together, our results document a key role for post-transcriptional gene regulation in tumor development and describe a detailed mechanism for gene expression reprogramming underlying malignant tumor progression.
KW - Tissue-plasminogen activator
KW - Gene-expression
KW - Pancreas cancer
KW - Cellular senescence
KW - Urokinase receptor
KW - Cells
KW - Mouse
KW - Cpeb
KW - Polyadenylation
KW - Growth
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=anu_research_portal_plus2&SrcAuth=WosAPI&KeyUT=WOS:000299018600033&DestLinkType=FullRecord&DestApp=WOS_CPL
U2 - 10.1038/nm.2540
DO - 10.1038/nm.2540
M3 - Article
C2 - 22138752
SN - 1078-8956
VL - 18
SP - 83
EP - 90
JO - Nature Medicine
JF - Nature Medicine
IS - 1
ER -